ORIGINAL RESEARCH

Laser therapy and unloading therapeutic gymnastics in the treatment of dyslipoproteinemia

Achilov AA1,2, Baranov AV1, Gornov SV2, Usmonzoda DU4, Achilova SA5, Pulatova MD6, Achilov AlA3, Mamedyarova IA7, Lazechko MI1
About authors

1 The Skobelkin Research and Practical Centre for Laser Medicine of the Federal Medical-Biological Agency, Moscow, Russia

2 Russian Biotechnological University, Institute of Medical Continuous Education, Moscow, Russia

3 Vishnevsky Central Military Clinical Hospital of the Russian Federation Defence, Moscow, Russia

4 Diagnostic Clinical Center № 1 of the Moscow City Health Department, Branch 3. Moscow, Russia

5 SCOLMED LLC, Zarechye, Moscow, Russia

6 Municipal Polyclinic № 134 of the Moscow City Health Department, Moscow, Russia

7 Azerbaijan Medical University, Baku, Azerbaijan

Correspondence should be addressed: Maryana I. Lazechko
Studentcheskaya, 40, Moscow, 121165, Russia; ur.demsalsog@m.okhcezal

About paper

Author contribution: Achilov AA — methodology development, collection and statistical processing of data, manuscript writing; Baranov AV — study concept, scientific supervision, manuscript editing; Gornov SV — study concept, scientific supervision, literature review, manuscript writing; Usmonzoda DU — data collection, literature review, manuscript writing; Achilova SA, Pulatova MD, Achilov Al.A, Mamedyarova IA — data collection, literature review; Lazechko MI — literature review, study design, manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Skobelkin Research and Practical Centre for Laser Medicine of the Federal Medical-Biological Agency (protocol № 2/23 dated 18 December 2023). All patients submitted the informed consent to study participation.

Received: 2023-12-19 Accepted: 2024-02-24 Published online: 2024-03-25
|
Table 1. Distribution of IHD patients with LMD resistant to LLD by gender and age
Table 2. Initial parameters of lipid metabolism and ET in healthy individuals and LLT-resistant IHD patients (M ± m) with ongoing maintenance pharmacotherapy
Note: * * — statistically significant differences between initial values in patients compared to values in healthy individuals (p¹ < 0.01); NS — differences between OG initial values and CG initial values are statistically insignificant (p²); TC — total cholesterol; HDL-C — high-density lipoprotein cholesterol; LDL-C — low-density lipoprotein cholesterol; AC — atherogenic coefficient, TG — triglycerides; ET — exercise tolerance.